Results 311 to 320 of about 259,075 (330)

Treatment-resistant depression and suicidality

Journal of Affective Disorders, 2018
Thirty percent of patients with treatment-resistant depression (TRD) attempt suicide at least once during their lifetime. However, it is unclear what the attempted and completed suicide incidences are in TRD patients after initiating a treatment, and whether specific treatments increase or decrease these incidences.We searched PubMed systematically for
Isidoor O. Bergfeld, Mariska Mantione, Martijn Figee, P. Richard Schuurman, Anja Lok, Damiaan Denys   +5 more
openaire   +2 more sources

ECT in Treatment-Resistant Depression

American Journal of Psychiatry, 2012
Electroconvulsive therapy (ECT), which has been in use for 75 years, is an important treatment for severe and treatment-resistant depression. Although it is acknowledged as the most effective acute treatment for severe mood and psychotic disorders, it remains controversial because of misperceptions about its use and lack of familiarity among health ...
Charles H, Kellner, Robert M, Greenberg, James W, Murrough, Ethan O, Bryson, Mimi C, Briggs, Rosa M, Pasculli   +5 more
openaire   +2 more sources

Management of Treatment-Resistant Depression

Psychiatric Clinics of North America, 2012
Given the limitations of evidence for treatment options that are consistently effective for TRD and the possibility that TRD is in fact a form of depression that has a low probability of resolving, how can clinicians help patients with TRD? Perhaps the most important conceptual shift that needs to take place before treatment can be helpful is to accept
Gabor I, Keitner, Abigail K, Mansfield
openaire   +2 more sources

Esketamine for Treatment-Resistant Depression - First FDA-Approved Antidepressant in a New Class.

New England Journal of Medicine, 2019
Esketamine for Treatment-Resistant Depression The FDA has approved esketamine, the first antidepressant in a new class, for treatment-resistant depression.
Jean Kim, Tiffany R. Farchione, Andrew Potter, Qi Chen, R. Temple   +4 more
semanticscholar   +1 more source

Venlafaxine and treatment-resistant depression

Depression and Anxiety, 2000
Treatment-resistant depression (TRD) is an important clinical problem. This paper briefly reviews the definition of TRD and summarizes methodological issues that pertain to treatment research. Recent studies of venlafaxine treatment for TRD also are reviewed.
M E, Thase, E S, Friedman, R H, Howland
openaire   +2 more sources

Esketamine for treatment resistant depression

Expert Review of Neurotherapeutics, 2019
Introduction: Treatment Resistant Depression (TRD) is a common and burdensome condition with poor outcomes and few treatment options. Esketamine is the S-enantiomer of ketamine and has recently been FDA approved in the United States for treating depression that has failed to respond to trials of two or more antidepressants.
Jennifer, Swainson, Rejish K, Thomas, Shaina, Archer, Carson, Chrenek, Mary-Anne, MacKay, Glen, Baker, Serdar, Dursun, Larry J, Klassen, Pratap, Chokka, Michael L, Demas   +9 more
openaire   +2 more sources

Treatment-Resistant Depression

Fortschritte der Neurologie-Psychiatrie, 2010
Marc Turiault, Caroline Cohen, Guy Griebel, David E. Nichols, Britta Hahn, Gary Remington, Ronald F. Mucha, Emma Childs, Darren R. Christensen, Warren K. Bickel, Darren R. Christensen, Warren K. Bickel, Andrea Bari, Rosa M. M. de Almeida, Klaus A. Miczek, Sheldon Preskorn, Megan M. Dahmen, Janka Lincoln, Emma Childs, Tomasz Schneider, Pierre Baumann, Britta Hahn, W. Wolfgang Fleischhacker, W. Wolfgang Fleischhacker, W. Wolfgang Fleischhacker, Trevor W. Robbins, Emma Childs, Lawrence Scahill, Lawrence Scahill, Lawrence Scahill, Lawrence Scahill, Ben J. Harrison, Christos Pantelis, Warren H. Meck, Catalin V. Buhusi, Catalin V. Buhusi, Warren H. Meck, Warren H. Meck, Catalin V. Buhusi, Seiya Miyamoto, Harriet de Wit, David C. S. Roberts, Robert L. Balster, Robert Kessler, Ronald L. Cowan, Johannes Mosbacher, Emma Childs, Sara Tomlinson, Glen B. Baker, Sara Tomlinson, Glen B. Baker, Mark Slifstein, Suzanne H. Mitchell, Harriet de Wit, Tara L. White, Richard A. Depue, Martine Cador, Lawrence H. Price, Jean-Michel Scherrmann, Etienne Sibille, Nicole Edgar, Christof Baltes, Thomas Mueggler, Markus Rudin, Thomas Steckler, Josee E. Leysen, Stephen M. Stahl, Meghan M. Grady, Klaus A. Miczek, Joseph Zohar, Klaus A. Miczek, Linda Lundström, Silvia Gatti McArthur, Will Spooren, Gary Remington, Ashwini Padhi, Naomi A. Fineberg, Josee E. Leysen, Emma Childs, Robert L. Balster, Subhash C. Pandey, Michael H. Bloch, Sidney H. Kennedy, Sakina J. Rizvi, Clemens Kirschbaum, W. Wolfgang Fleischhacker, Harriet de Wit, Theodora Duka, David S. Middlemas, David B. Bylund, A. Claudio Cuello, David E. Nichols, Lawrence H. Price, Simon N. Young, Peter Verhaert, Per Svenningsson, Per E. Andrén, Tiffany Thomas, Robert L. Findling   +98 more
  +5 more sources

Defining Treatment-Resistant Depression

JAMA Psychiatry, 2017
David L, Fogelson, Andrew, Leuchter
openaire   +2 more sources

Treatment resistant depression.

Psychiatric journal of the University of Ottawa : Revue de psychiatrie de l'Universite d'Ottawa, 1989
Despite major research efforts in mood disorders, careful scientific studies and evaluations of "treatment resistant depression" (TRD) are limited. Treatment resistant depression often encompasses several conflicting definitions and concepts: (1) the distinction between 'absolute' TRD and 'relative' TRD is seldom made; (2) the combination of a ...
openaire   +1 more source

Treatment-Resistant Depression: Approaches to Treatment.

Journal of Psychosocial Nursing and Mental Health Services, 2021
Karan S Kverno, Emma Mangano
semanticscholar   +1 more source